Rafael Holdings, Inc. Class B (RFL): Price and Financial Metrics


Rafael Holdings, Inc. Class B (RFL): $1.92

-0.04 (-2.04%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

RFL POWR Grades

  • RFL scores best on the Sentiment dimension, with a Sentiment rank ahead of 77.07% of US stocks.
  • The strongest trend for RFL is in Sentiment, which has been heading up over the past 134 days.
  • RFL's current lowest rank is in the Growth metric (where it is better than 3.3% of US stocks).

RFL Stock Summary

  • RFL's price/sales ratio is 114.6; that's higher than the P/S ratio of 97.89% of US stocks.
  • Revenue growth over the past 12 months for RAFAEL HOLDINGS INC comes in at -89.68%, a number that bests just 1.33% of the US stocks we're tracking.
  • RAFAEL HOLDINGS INC's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -221.04%, greater than the shareholder yield of only 2.66% of stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to RAFAEL HOLDINGS INC are OBLG, PAAS, ETWO, FF, and KERN.
  • RFL's SEC filings can be seen here. And to visit RAFAEL HOLDINGS INC's official web site, go to www.rafaelholdings.com.

RFL Valuation Summary

  • RFL's price/sales ratio is 117.1; this is 2339.58% higher than that of the median Healthcare stock.
  • Over the past 57 months, RFL's EV/EBIT ratio has gone down 252.4.

Below are key valuation metrics over time for RFL.

Stock Date P/S P/B P/E EV/EBIT
RFL 2022-11-25 117.1 0.5 -0.4 -0.3
RFL 2022-11-23 119.3 0.5 -0.4 -0.3
RFL 2022-11-22 117.1 0.5 -0.4 -0.3
RFL 2022-11-21 120.0 0.5 -0.4 -0.3
RFL 2022-11-18 117.1 0.5 -0.4 -0.3
RFL 2022-11-17 119.3 0.5 -0.4 -0.3

RFL's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • RFL has a Quality Grade of D, ranking ahead of 24.16% of graded US stocks.
  • RFL's asset turnover comes in at 0.027 -- ranking 59th of 63 Real Estate stocks.
  • 500 - Internal server error

The table below shows RFL's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-07-31 0.027 1 -0.188
2021-04-30 0.030 1 -0.139
2021-01-31 0.032 1 -0.138
2020-10-31 0.035 1 -0.083
2020-07-31 0.035 1 -0.082
2020-04-30 0.036 1 -0.050

RFL Stock Price Chart Interactive Chart >

Price chart for RFL

RFL Price/Volume Stats

Current price $1.92 52-week high $6.47
Prev. close $1.96 52-week low $1.60
Day low $1.92 Volume 3,262
Day high $1.92 Avg. volume 132,161
50-day MA $1.86 Dividend yield N/A
200-day MA $2.13 Market Cap 39.94M

Rafael Holdings, Inc. Class B (RFL) Company Bio


Rafael Holdings, Inc., through its subsidiary, manufactures metabolic oncology drugs to treat cancer. The company also owns and operates real estate properties. The company was incorporated in 2017 and is based in Newark, New Jersey. Rafael Holdings, Inc. operates as a subsidiary of IDT Corporation


RFL Latest News Stream


Event/Time News Detail
Loading, please wait...

RFL Latest Social Stream


Loading social stream, please wait...

View Full RFL Social Stream

Latest RFL News From Around the Web

Below are the latest news stories about RAFAEL HOLDINGS INC that investors may wish to consider to help them evaluate RFL as an investment opportunity.

Rafael Holdings to Focus on Strategic Business Development Initiatives and Curtail Early Stage Development Activities

NEWARK, N.J., Nov. 15, 2022 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL) today announced its decision to curtail its early-stage development efforts, including pre-clinical research at the Barer Institute in order to reduce spending and focus on exploring strategic opportunities to invest in, acquire, or in-license clinical stage assets. As of July 31, 2022, the Company held cash, cash equivalents and marketable securities of $63.2 million, and subsequently received $33 million in net p

Yahoo | November 15, 2022

Rafael Holdings Reports Fourth Quarter Fiscal 2022 Financial Results

NEWARK, N.J., Oct. 31, 2022 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL), a holding company with interests in clinical and early-stage pharmaceutical companies, today reported its financial results for the three and twelve months ended July 31, 2022. The Company is accelerating its focus on exploring strategic opportunities to further enhance value while continuing to develop and evaluate its pipeline. “With the net proceeds of $33 million received in August 2022 from the sale of real e

Yahoo | October 31, 2022

Cornerstone Pharmaceuticals Initiates Phase 1 Trial of CPI-613® (devimistat) in Combination with Chemoradiation for the Treatment of Advanced Pancreatic Cancer

Clinical program advancement represents key milestone for Cornerstone underscoring its commitment to the development of lead compound, devimistat, in pancreatic cancerCranbury, Sept. 28, 2022 (GLOBE NEWSWIRE) -- September 28, 2022 - Cornerstone Pharmaceuticals, Inc., a company focused on rare cancer therapeutics and formerly known as Rafael Pharmaceuticals, today announced the initiation of a Phase 1 clinical trial evaluating CPI-613® (devimistat) in combination with chemoradiation for the treat

Yahoo | September 28, 2022

Rafael Holdings Sells its Building Located at 520 Broad Street in Newark, New Jersey and Associated 800-Car Public Garage

NEWARK, N.J., Aug. 23, 2022 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc., (NYSE: RFL), an early-stage novel cancer and immune metabolism therapeutics company, today announced that it has closed on the sale of the building housing its headquarters to affiliates of The Sinai Equity Group. The building located at 520 Broad Street in Newark, New Jersey and an associated 800-car public garage sold for a total purchase price of $49.4 million. Rafael Holdings expects net proceeds of approximately $33 mill

Yahoo | August 23, 2022

A Quick Glance At Rafael Holdings Inc. (NYSE: RFL) Stock: It Is up 17.1% From Its 52-Week Low; YTD, It Is Down -62.16 Percent

During the last session, Rafael Holdings Inc. (NYSE:RFL)’s traded shares were 0.16 million, with the beta value of the company hitting 1.87. At the end of the trading day, the stock’s price was $1.93, reflecting an intraday loss of -3.02% or -$0.06. The 52-week high for the RFL share is $56.00, that puts it down … A Quick Glance At Rafael Holdings Inc. (NYSE: RFL) Stock: It Is up 17.1% From Its 52-Week Low; YTD, It Is Down -62.16 Percent Read More »

Marketing Sentinel | August 6, 2022

Read More 'RFL' Stories Here

RFL Price Returns

1-mo -0.52%
3-mo -9.00%
6-mo 3.23%
1-year -65.84%
3-year -88.46%
5-year N/A
YTD -62.35%
2021 -78.13%
2020 30.72%
2019 124.97%
2018 N/A
2017 N/A

Continue Researching RFL

Want to see what other sources are saying about Rafael Holdings Inc's financials and stock price? Try the links below:

Rafael Holdings Inc (RFL) Stock Price | Nasdaq
Rafael Holdings Inc (RFL) Stock Quote, History and News - Yahoo Finance
Rafael Holdings Inc (RFL) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6753 seconds.